Typicality: | 0.589 |
Saliency: | 0.415 |
in practice-based screening | 9 | other |
regardless of risk status | 6 | other |
by trained clinical research coordinators | 2 | other |
questionnaire → be administered to → patient | 17 |
questionnaire → be answered by → patient | 4 |
questionnaire → be used in → patient | 3 |
negative | neutral | positive |
0.151 | 0.788 | 0.061 |
Raw frequency | 24 |
Normalized frequency | 0.415 |
Modifier score | 1.000 |
Perplexity | 55.212 |